Abstract -We have analysed 994 sites for oncogenes and tumour suppressor genes located within human chromosome bands. The data presented disclose that: 1) These cancer genes build ridges as well as hot spots, which are not related to the position of other types of genes present in these chromosomes.
INTRODUCTION
Cancer is not a disease in the conventional sense of the word. This is because cancer is an obligatory component of the cell's original construction. Its emergence derives primarily from a shift, or disturbance, in the time of expression of the organisms' most vital genes.
The formation of an organism from a single fertilized egg involves the production of several millions of cells. The construction of such an enormous cellular edifice is possible thanks to strict and ordered genetic controls. Following this primary process the genes which are responsible for the highly organized and coherent development of the embryo are successively silenced once their task is accomplished. The cell differentiation and organization which occur during this period is under the control of well defined clusters of genes, such as those of the homeobox (Lawrence 1992; Scott 1992; Rawls et al. 2004) .
A striking feature of these genes is that their order along the chromosome within the box is related to the order of the segments formed along the body axis of the embryo. This occurs both in invertebrates and vertebrates including humans. Moreover, the hierarchic and directive functions of the homeobox have been preserved throughout evolution, being present in the simplest invertebrates, plants and humans (Katz et al. 2004) . Rigid order in gene sequence and rigid order in gene action are the hallmark of normal development (Maconochie et al. 1996; Goodrich et al. 1997; Parcy et al. 1998; Wen et al. 2004) . But it must be kept in mind that the formation of an embryo not only involves cell proliferation, but it is accompanied by gene interactions that suppress, at the proper time and location, the further division of cells.
Oncogenes happen to be a class of vital genes, involved in the critical steps of the embryonic cascades, which suddenly, instead of maintaining their silence, become highly active in transcription (Brugge et al. 1991) . This process is mainly dependent on their interplay with tumour suppressor genes. These have kept the action of oncogenes under a control that can be released. This new situation may be due to novel interactions arising among genes, to the formation of chromosomal and gene rearrangements, or caused by cell environmental factors such as viruses and chemicals (Varmus and Weinberg 1993; Levine 2002; Mitelman et al. 2004) . Hence, the basic process implicated in the emergence of cancer is essen-tially one of control of gene function and one of gene interaction within and between chromosomes.
For several years the understanding of gene interaction and coordination has been approached from several points of view, but the evidence available has been so scanty that it has remained a sideline in the huge project of cancer research. Without an exact location of oncogenes and tumour suppressor genes in the human chromosomes, and a study of their DNA sequences, no significant progress could be obtained in this area.
A preliminary attempt was made when the localization, of the first 20 retroviral and nonretroviral oncogenes, became known in the bands of human chromosomes (Lima-De-Faria and Mitelman 1986) . This analysis revealed that these oncogenes were not localized at random, their distribution displaying the following features: 1) They tended to be less represented in the 8 shortest arms of the complement (below 1.1 microns) as well as in the two longest arms of the complement (above 4.3 microns). 2) They tended to be in the 1/3 of the chromosome arm which was located closest to the telomeres.
A few years later 42 proto-oncogenes had been localized in human chromosomes. The same pattern of distribution was maintained when the number of cancer genes was doubled (Lima-DeFaria et al. 1991) . But the data continued to be too limited to allow to obtain a clear picture of the significance of their distribution.
The DNA sequencing of the human genome (International Human Genome Sequencing Consortium 2001 and Venter et al. 2001) and the active collaboration of many laboratories involved in cancer research, changed radically this situation. At present 373 oncogenes and 455 tumour suppressor genes have been assigned to one or a few specific bands, in the 24 human chromosomes ("Online Mendelian Inheritance in Man" from the National Center for Biotechnology Information, authored and edited by VICTOR A. MCKUSICK, Johns Hopkins University). This led to 994 sites being located within well defined limits.
Surprisingly the present study corroborates the pattern of distribution discovered earlier and moreover discloses novel features of significance for gene interaction and chromosome organization in which telomeres and nucleolus organizers seem to interfere with the territory of cancer genes. The results point to the need to look for other DNA functions, than those that are conventionally ascribed to DNA, such as the roles of new RNA types which carry out information between DNA sequences along entire arms and entire chromosomes (Avner and Heard 2001 , Brockdorff 2002 , Luo et al. 2004 .
The present information available on cancer genes contains pitfalls and uncertainties. The same is the case of the extensive gene maps, so far published, with their uncharted regions and inadequate information. However, if these limitations are taken into careful consideration, the data on cancer genes can be combined with that from the gene maps, furnishing a preliminary, but valuable view of hidden phenomena that shed light on gene and chromosome organization.
MATERIALS AND METHODS
I. The source of the data. The data used in this work were gathered from "OMIM Online Mendelian Inheritance in Man" Johns Hopkins University (030416) and from the "National Center for Biotechnology Information" National Library of Medicine, National Institutes of Health (040127).
The oncogenes listed are described by number, name and some of their properties. This information is accompanied in most cases by their location in: 1) a specific chromosome, 2) a chromosome arm, 3) a group of bands or 4) a single band.
These data allow to have an accurate knowledge of the location of oncogenes in chromosome bands permitting to find out whether their distribution is random or related to chromosome structure or gene organization.
The oncogenes totalled 422. A screening of their location revealed the following: 1) Of the listed oncogenes, 37 lacked a gene map locus. As a consequence they were not included in the present study.
2) The number of oncogenes located in a whole chromosome were 7 and in a whole long arm were 4. These were not either included.
3) Nine oncogenes occurred in different locations (sites) within the same chromosome. The number of sites varied from 2 to 4. 4) In 26 cases an oncogene was located in different chromosomes. The number of sites varied from 2 to 13 and the chromosomes involved were 2 to 9.
The listed tumour suppressor genes totalled 500. 1) Of these, 33 lacked a gene map locus and for this reason were not included.
2) Also not included, were 6 which covered a whole chromosome and 5 which stretched over a whole arm. An exception was the case in which the whole arm was very small, as in the nucleolar arm of chromosome 21 (suppressor 390).
3) Eighteen suppressors occurred at different sites within the same chromosome. 4) In 32 cases the same suppressor gene was located in different chromosomes. The number of sites (per suppressor) varied from 2 to 15 and the number of chromosomes involved in the transfer varied from 2 to 9.
As a result 373 oncogenes and 455 suppressors were located on the chromosome maps (after three more genes were considered uncertain).
II. The banding pattern.
The banding pattern used as a reference was that compiled by Strachan and Read (2000) . This has been described as "a compilation of the best banding patterns that might be seen on each chromosome". The number of bands in the human complement is considered to be about 550, but this figure oscillates between 400 and 850 depending on the stage at which the chromosomes were banded. The banding represents a differential staining of the chromosomes by different techniques and partly reflects their GC content, dark bands being characterized by lower GC content than light bands. Protein coding genes are also supposed to be more concentrated in light bands. The average length of a human chromosome is 130 million base pairs (Mb) (variation 51 to 279 Mb) the average band length is 6 Mb (Strachan and Read 2004) . But bands vary appreciably in size, some being larger that 3 adjacent small ones taken together. However, the location of genes in specific bands is a most valuable step in the direction of getting information on chromosome organization, because the precision of the localization, in bands and DNA sequences, is increasing rapidly (Fig. 1) .
The average size of a band (6Mb) may seem too large to give a good resolution of gene location, but some of the largest human genes have great dimensions. For example, the dystrophin gene is 2.4 Mb (Tennyson et al. 1995) . Hence, a whole human structural gene may be larger than many of the small bands.
III. Degree of accuracy of gene location. The data on the oncogenes and tumour suppressor genes (total 828) revealed that 54.4% were located on a single band and that 35.0% occupied 2 or 3 bands. The remaining 10.6% had locations ranging from 4 to 7 bands. In each case, where more than one band was involved, the middle region was chosen as the location of the gene. An appreciable number of genes had more than one location on the same or other chromosomes (in some cases extending to 15 for a single gene). As a result the number of sites mapped on the chromosomes is higher (994) as compared to the number of genes (828). Since 89.4% of all the genes were located in less than 3 bands the accuracy of the location is, on the average, 18 million base pairs or less.
IV. Graphic representation of gene location in relation to centromeres and telomeres. To find out whether specific DNA sequences and structural genes in human chromosomes have a location related to centromeres and to telomeres the following arm frame method was used (Lima-De-Faria 1973 , 1983 , 2003 . There are 46 chromosomes in the human diploid complement but there are 48 arms which are different (1-22 autosomes + X and Y). The length of these arms extends from 0.3 microns in the short arm of chromosome Y (Yp) to 4.7 microns in the long arm of chromosome 2 (2q). All the chromosome arms have been aligned after their length, irrespective of the chromosome to which they belong, with all the centromeres on the same vertical line and the telomeres occupying an increasing distance from the centromere, as the arm length increases. Several arms have the same length, and as such occupy the same place on the graph (Fig. 2) .
Each arm was divided into three regions of equal length: 1) nearest centromeres 2) median part of each arm and 3) nearest telomeres. As a result the length of each of these three regions increases with arm length. Genes occupying region 1 have been called centrons; region 2, medons; and region 3, telons (Lima-De-Faria 1980) . This means that, for instance, centrons in the short arm of the Y occupy only 0.1 micron, whereas in the long arm of chromosome 2 they extend over 1.6 microns ( Fig. 2) .
V. Limitations of the lists available from OMIM.
We are aware that there are pitfalls and inadequacies in the lists of oncogenes and suppressor genes published by OMIM. The occurrence of pseudogenes, the existence of syndromes dependent on different genes and the occurrence of designations given by different laboratories, contribute to create a series of uncertainties in these lists. However, any selection made on the lists would have led to solutions based on various criteria, which colleagues from different laboratories, would have accepted or refuted, depending on their experience in the field. The lists were used at their face value since they have been authored and edited by Victor a. Mckusick, a leading expert in this field. More knowledge is accumulating rapidly and the minor discrepancies present will be successively resolved as further information becomes available.
VI Definition of oncogenes and suppressors.
Oncogenes, were originally defined by Varmus and collaborators as: "Genes that induce uncontrolled cell proliferation" (Parker et al., 1981) . Suppressors have been defined as gene mutations that "suppress the effect of a mutation in another gene or in the same gene" (King and Stansfield, 1997) . These are the definitions generally adopted, but their limits are sometimes elusive (Snyder and Gerstein, 2003) .
To control whether our data agreed with the last report, covering the genes that are being considered as oncogenes, we made an analysis of the data of Mitelman et al. (2004) . We localized the chromosomal position of 269 of their 275 reported cancer genes. The chromosomal distribution turned out to be almost identical from both their cancer gene data set and the OMIM cancer gene data set (see end of discussion).
RESULTS
The distribution of the genes reveals the following properties. 
1) Concentration of cancer genes in ridges.
Both oncogenes and suppressors are not distributed at random in all the chromosomes of the complement (Fig. 1) . They tend to be concentrated on specific bands or small groups of bands. This is particularly evident on chromosomes 1, 3, 7, 9, 10, 11, 13, 16, 17, 19 and 22. 2) Hot spots. As many as 36 suppressor sites are located on a single band on chromosome 3 (21.3p). Other suppressors show similar clustering restricted to one band. There are 10 suppressor sites on chromosome 11 at 15.5p, 12 on the same chromosome at 13.2q and 16 on chromosome 17 at 13p.
The same is true for oncogene sites. 7 are on band 36.2p of chromosome 1, 12 on 13.2q of chromosome 11, 8 on 13p of chromosome 17, and 6 on 13.1q of chromosome 22. These are considered to be hot spots.
3) Relationship to structural gene distribution.
Under each chromosome is displayed the distribution of all known genes retrieved from the NCBI Entrez Genome OMIM Master Map: Genes on sequence (040127, revised 031203). It can be seen that there is no obvious relationship between the distribution of the normal structural genes and that of oncogenes or suppressors. The ridges and hot spots of cancer genes do not occur at chromosome regions that show particularly high density of structural genes. However, the comparison of chromosomes 18 with 19 discloses that chromosome 19 has more genes than 18 (1.512 versus 368) and that 22 has more genes than 21 (673 versus 285) from the data on the map gene density. It also turns out that chromosome 19 has more sites of oncogenes and suppressors (37) than chromosome 18 (only 18) and this situation is still more evident when 21 is compared with 22 (a total of 7 in chromosome 21 versus 37 in chromosome 22).
4) Lack of cancer genes in nucleolar arms.
In the human complement there are 5 chromosomes Fig. 2 -The red triangular frame consists of all the arms of the human complement. The arms of chromosomes 1 to 22 plus those of the X and Y (a total of 48 arms) have been distributed according to their length irrespective of the chromosome to which they belong. All the centromeres (C) occupy a straight line, and the telomeres (T) are all located along a line that follows the increasing length of each arm (in microns). Arms which have the same length occupy the same position in the graph. The shortest arm is that of the Y chromosome, it measures 0.29 microns (Yp). The longest arm is that of chromosome 2, with 4.67 microns (2q). Each arm, irrespective of its length, has been divided into 3 equal parts: a region nearest the centromere, a median region and a telomeric region. Genes that are located in the first, second and third regions are called centrons, medons and telons, respectively. The distribution of the sites, on which are located the 994 oncogenes and suppressors, is shown by three standing blue pillars. There are: 422 telons (42.5%), 311 medons (31.3%), 261 centrons (26.3%). Not only most cancer genes tend to occupy a position in the distal telomeric region, but also their distribution follows a gradient since their numbers decrease successively as they occur further away from the telomeres. The statistical analysis of the data displayed in this figure and in figures 5, 6, and 8 gave, in each case, a X 2 that was highly significant (see Results). 
7) Preference for the telomeric region.
The main feature of the distribution of both types of cancer genes is that they tend to be not only located at telomeres but also in the 1/3 region of the chromosome arm that is closest to the telomere (telon area). This is mostly evident in the short arms of chromosomes 1, 4, 8, 11, 16, 17 and 19 ; but also in the long arms of chromosomes 5, 8, 9, 10, 11, 14, 16, 17, 19, 20, 21, 22 and X. There are also obvious cases in which these genes appear clustered near centromeres, as in chromosomes 10, 11, 13, 17, 20, 22 and X. In some instances there is a concentration in median regions as in chromosomes: 3 (short arm), 7 (long arm), 9 (short arm), 11 (short arm), 17 (long arm), 18 (long arm) and 22 (long arm). However, when each chromosome arm is divided into its 3 regions: centromeric, median and telomeric, the 994 cancer sites display two features: 1) 422 are telons, 311 are medons and 261 are centrons. This means that nearly half are located in the telomere region (42.5%) whereas only 26.3% are centrons. 2) Another feature is that they decrease in numbers from the telomere to the centromere building a distinct gradient (Fig. 2) . The statistical analysis reveals an X 2 of 40.98 giving a P = 1.2 x 10 -9
, a value which is extremely significant.
8) Comparison of the number of sites of oncogenes plus tumour suppressor genes with the total number of structural genes.
Again this relationship discloses definite preference for certain chromosomes. Chromosomes nr. 3, 10, 11, 13, 17 and 22 have the highest values for cancer genes when compared to the number of structural genes so far identified in their chromosomes. Displaying an underrepresentation are chromosomes 14, X and Y (Fig. 3) .
9) Number of sites of oncogenes and tumour suppressor genes and its relationship to chromosome length.
The distribution of the oncogenes and suppressor genes is far from random. Their distribution does not follow the decrease in length of the chromosomes. Chromosomes 1, 3, 11 and 17 have the highest values not related to their length. There is not either a successive decrease with length, chromosome nr. 4 (one of the large autosomes) has less cancer genes than the smallest autosome nr. 22. Chromosomes in which cancer genes are underrepresented are the long chromosome nr. 2 and the X, which is as long as chromosome nr. 7, yet it contains less than half cancer genes (Fig. 4) .
10) The density of cancer genes per chromosome arm. When, instead of using whole chromosomes, the density of cancer genes is calculated for single arms, a more striking deviation becomes evident. The chromosome arms increase in length from Yp (0.29 microns) to the largest value in 2q (4.67 microns) (Fig. 5) . The following emerges: 1) The short arms of chromosomes 22, 21, 15, 13, and 14 (which are the nucleolar arms) display an absence of cancer genes (except 21p which has a single suppressor).
2) The chromosome arms: 17p, 22q, 11p, 17q and 3p show the highest density, stand- the non-random location of human oncogenes and tumour suppressor genesing out clearly. 3) The 8 longest arms of the complement (6q to 2q) instead of having the highest density show less than average values. The statistical treatment discloses that X 2 equals 157.64 giving a P = 4.64 x 10 -22 which is extremely significant.
11) The frequency of cancer genes compared with the number of DNA bases per chromosome.
There is not either a direct relationship between the number of bases in each chromosome and the number of cancer genes. Chromosomes 3, 11, 17, 19 and 22 stand out as having distinctly a higher number of cancer genes than the others when this number is compared to their length in million base pairs (Fig. 6 ). In this case X 2 equals 307.78 giving a P = 1.11 x 10 -51 which is also extremely significant.
12) Number of sites of cancer genes which occur more than once within the same chromosome.
A relevant feature, of both the oncogenes and the suppressors, is that the same gene can occur at different sites within the same chromosome. Transposons may be involved in this process. Some chromosomes are much more prone to this phenomenon than others. Chromosomes nr. 3, 10, 17 and 22 distance themselves (Fig. 7) .
13) The preference of multiple sites for specific chromosomes within the complement. At the same time that cancer genes show multiple sites within a single chromosome they also exhibit multiple sites which occupy different chromosomes. Suppressors and oncogenes, having multiple sites, were found to spread over all the chromosomes of the complement, appearing a large number of times on most chromosomes. However, in a total of 58 genes (32 suppressors and 26 oncogenes) these were found to have a preference for specific chromosomes. Chromosomes nr. 3, 10, 11, 17 and 22 show the highest number of times in which this event has occurred (26, 25, 22, 22 and 11 respectively) whereas chromosomes 6 and 20 display the lowest values (only twice and once respectively).
14) The distribution in gradients of cancer genes in the short and the long arms of the autosomes, excluding the nucleolar chromosomes. It becomes mandatory to separate the nucleolar chromosomes from the other autosomes, because cancer genes show a totally different distribution in the nucleolar chromosomes.
The autosomes nr. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 16, 17, 18, 19, and 20 , display a distribution of the cancer genes which: 1) has the maximum number of these genes near telomeres. 2) There is a decrease in the number of genes towards the centromere building a distinct gradient.
3) This gradient is much more steep in the short arms than in the long arms. In the long arms the values are: 202 telons (23.8%), 157 medons (18.5%) and 144 centrons (16.9%). In the short arms 175 telons (20.6%), 111 medons (13.1%) and 59 centrons (6.9%). The average length of all these short arms is 1.65 microns and of these long .29 microns) and the longest is 2q (4.67 microns). The density is expressed as the number of cancer genes per arm length. This is shown by blue bars located at the side of each arm. The six shortest arms show only two sites (one in Yp and one in 21p). The arms 17p, 22q, 11p, 17q and 3p stand out distinctly. Contrary to expectation the eight longest arms (6q to 2q) have density values which are below average. lima-de-faria and widegren arms is 2.85 microns (Fig. 8) . For the long arms X 2 equals 11.05 giving a P = 0.004; for the short arms X 2 equals 58.7 and P = 1.8 x 10 On one hand, some chromosomes are totally devoid of cancer genes that occur at more than one site. These are chromosomes 4, 6, 12 to 16 and 18 to 21. On the other hand, on chromosomes 3, 10, 17 and 22 many cancer genes occupy more than one site. Chromosome 10 is especially prone to this phenomenon which indicates an active role of transposons. pressed sequence tags). This approach is valuable but it contains several pitfalls because new data are revealing novel genetic situations which are not evident from these maps (Tycowski et al. 1993; Brockdorff 2002 , Luo et al. 2004 .
The maps also furnish a simplified picture of gene distribution, excluding many regions. The gene maps displayed under every human chromosome on Fig. 1 were obtained from NCBI Genome (Homo sapiens genome data and search tips, November 2003). These maps show a series of well delimited regions devoided of genes. These are: 1) Chromosome 1, long arm, block adjacent to centromere, 1q12. 2) Chromosome 9, long arm, block adjacent to centromere, 9q12. 3) Chromosome 13, whole short arm, 13p11.1-p13. 4) Chromosome 14, whole short arm, 14p11.1-p13.5) Chromosome 15, whole short arm, 15p11.1-p13. 6) Chromosome 16, long arm, block adjacent to centromere, 16q11.2. 7) Chromosome 19, short arm, block adjacent to centromere, 19p11-p12. 8) Chromosome 21, whole short arm, 21p11.1-p13. 9) Chromosome 22, whole short arm, 22p11.1-p13. 10) Y chromosome, long arm, median and distal regions, Yq11.23-q12.
Besides these regions, all the 22 + X and Y centromeres are displayed as gaps without genes.
Many genes are present in nucleolar arms but there is a near absence of cancer genes in these arms.
As mentioned above the nucleolar arms of the 5 chromosomes 13, 14, 15, 21, 22 have been depicted as empty of genes in the maps. Yet it is known that not only do they contain a total of 250 copies (tandemly repeated) of the genes for 28S and 18S ribosomal RNA, but most important they harbor as much as 200 genes for small nuclear RNAs (Smith and Steitz 1997; Strachan and Read 2000) .
This means that the 5 nucleolar arms contain hundreds of DNA sequences that code for different RNA types. What is remarkable is that of the 994 cancer sites only one was found to be located in these five arms (21p11.3, suppressor nr. 390 "Transmembrane Phosphatase with tensin homology"). Moreover, these arms contain a total of not less than 72 million base pairs of DNA, which is ample space for the location of hundreds of cancer genes. Equally long stretches of DNA, located in other chromosome arms, are loaded with cancer genes, as is, for instance, the long arm of chromosome 22, which belongs to a nucleolar chromosome, but which has no nucleolus on this arm. The lack of cancer genes in these 5 arms is indication of an inhibitory effect of the nucleolus organizer, or its adjacent sequences, on the genes involved in tumour formation. If this phenomenon would have appeared in only one nucleolar arm, it could have been considered accidental, but its recurrence in the 5 nucleolar arms of the complement, makes us wonder whether a molecular mechanism is involved.
The telomeric preference of cancer genes may be connected with telomerase activity in cancer cells. The tendency of cancer genes to be located in the 1/3 of the chromosome arm, closest to the telomeres, is evident from the distribution of these genes in Figs 2 and 8. In the case of all the chromosome arms of the complement, 42.5% cancer genes occur in this region (Fig. 2) . And when the autosomes (with exception of the nucleolar chromosomes) are analysed in the same way, the same phenomenon is evident. In the short arms 20.6% are telons, and in the long arms 23.8% are also telons making a total of 44.4% (Fig. 8) . Moreover, in all cases there is a gradient in the distribution of the cancer genes, the decrease being from the telomeres to the centromeres where it reaches the values of 26.3% (Fig. 2) and 23.8% (Fig. 8 ) (6.9% in short arms plus 16.9% in long arms), a value which is close to half of that found in the vicinity of telomeres. The results from both figure 2 and figure 8 have been shown to be statistically significant (see above).
Telomerase activity, is not present, or reduced, in most differentiated somatic cells. However, normal stem cells of different origin, e.g. haematopoietic stem cells or neuronal stem cells, have a cell cycle dependent on the expression of telomerase activity. One of the gene expressions associated with the emergence of cancer is that the telomerase reverse transcriptase (hTERT) is active. This activity, enables the tumour cells to go through an indefinite number of cell divisions forming tumours. If the chromatin is active in the ends of the chromosomes, this could affect the gene expression further downstream. Such position effects are well known. In genes that, by translocation, have been relocated to active chromatin, the expression is normally increased. One good example is the translocations found in Burkitt lymphomas (B-cell lymphoma), where the myc oncogene, normally located on chromosome 8 (8q24.21), is translocated to the heavy chain of the immunoglobulin molecule, located on chromosome 14 (14q32.33), or translocated to either of the immunoglobulin light chain genes on chromosomes number 2 (kappa chain, 2p11.2) or 22 (lambda chain, 22q11.2) respectively (e.g. Pelicci et al. 1986) . Moreover, there might exist a relation between the chromosomal localization of certain genes, being hallmarks of stem cells, so that these are preferentially located more close to the chromosome ends. When the activity of the telomerase reverse transcriptase gene diminishes, then the activity of many telomeric genes may be reduced. The hTERT gene itself, is located very close to the end of the short arm of chromosome 5 (5p15.33).
The dependence of gene location on telomeres has been found following the DNA sequencing of Plasmodium falciparum. This work disclosed that the genes involved in antigenic variation are concentrated in the subtelomeric regions of the chromosomes where they undergo higher rates of genetic exchange (Gardner et al. 2002) .
Similarities between stem cells and cancer cells. In Table 1 , we have listed different functional aspects of stem cells and cancer cells. It has been reported, that in many cancers, cells with stem cell characters exist (Al-Hajj et al. 2003; Singh et al. 2003; and Kondo et al. 2004) . The characters listed in Table 1 are essential for both normal stem cells and for malignant tumour cells. Hence, it is plausible that malignant transformation preferentially takes place in stem cells or in early progenitor cells with most of the stem cell characteristics, listed in Table 1 , being intact. If not, these functions must be regained during the process of malignant transformation. Taken together, the telomeric territory might be a preferential location of cancer related genes and thereby also of stem cell genes.
The presence of ridges and hot spots in cancer genes suggest that their function is ordered. Clustering of genes in specific sites is a well known phenomenon. One of the best studied gene complexes has been the human leukocyte system A (HL-A) which consists of a large number of antigens (Svejgaard et al. 1975) and the immune response genes Ir. All these genes are located within a narrow region of chromosome No 6 in humans (Bodmer 1976) . At present it is known that the high gene density in the HLA region is partly due to the presence of several overlapping genes (Geraghty et al. 1992) . The major histocompatibility complex (MHC) is located on human chromosome 6p21.3-p22.2 (Abi- Rached et al. 2002) . There are 61 histone genes. Most are found in two Fig. 8 -Number of sites of oncogenes plus tumour suppressor genes in the short and long arms of all the chromosomes of the complement, except those of the 5 nucleolar chromosomes and of the X and Y. The average length of all these short arms is 1.65 microns, and of all these long arms is 2.85 microns. In short arms the frequency of cancer genes is as follows: telons 175 (20.6 %), medons 111 (13.1%), centrons 59 (6.9%). In long arms the corresponding values are: telons 202 (23.8%), medons 157 (18.5%), centrons 144 (16.9%). In both arms there is: 1) a distinct higher frequency of cancer genes near telomeres and 2) a successive decrease in number towards the centromere building a gradient. Of significance is that the gradient is much steeper in short than in long arms. The 5 nucleolar chromosomes are not included in the graph, because in them, like in the sex chromosomes, there seems to exist an inhibitory process excluding or reducing the number of cancer genes in most of their arms (see Fig. 1 and text) . However, the result obtained here -the predominance of the telomeric territory -is the same as when all the arms of the complement are pulled together (see Fig. 2 ). In both cases the differences are statistically significant (see Results). multifamily clusters in the short arm of chromosome 6 (Albig and Doenecke 1997) . But the clustering is accompanied by a more significant phenomenon which remains unexplained at the molecular level, i.e. the association of genes with similar functions within well defined boxes. The homeobox HOX gene family, which is involved in directing embryonic development, consists of approximately 10 genes on each of four chromosomes (13q13-14, Xq13-q22, 4q11-12, 5q31-33). Most significant is that HOX clusters show strong conservation of gene order throughout evolution and moreover the order of the genes in the cluster is related to the order of their expression during development both in humans, Drosophila, and plants (Scott 1992) .
Hence, the clustering of oncogenes and of suppressor genes is expected to be a particular case of a general phenomenon of chromosome organization. As such it raises the same type of questions: Are the clustered cancer genes overlapping? Do they have an order along the DNA that is related to the order of their function in tumour growth? Are there "DNA cancer boxes"?
In Table 2 we have depicted 21 cancer genes, as appearing in the CNRS Cancer Gene Data Base, localized on chromosome region 3p21.3. This is one of several distinct hot-spots in the complement, characterized by a high frequency of tumour suppressor genes and oncogenes (cf. Fig.  1 ). Remarkable is that these genes have been held together during mammalian evolution, as is the case of the major histocompatibility complex (MHC). The inspection of the mouse genome data base (MGI Mouse Genome Informatics from the Jackson Laboratory, 040608) reveals that the 21 human genes in this hot-spot (Table 2 ) are all closely located in a similar hot-spot on the telomeric region of chromosome 9 of the mouse. This demonstrates the conservation of their intimate position during species evolution.
The chromosomes of the complement which show the largest deviation in the occurrence of cancer genes. In the present study five features display a non-random distribution of oncogenes and suppressors. In each case certain chromosomes clearly deviate from the others. 1) Ridges and hot spots; chromosomes: 3, 9, 10, 11, 16, 17, 19 and 22 . 2) Number of cancer genes per chromosome; chromosomes: 1, 3, 11, 17, 19 and 22. 3) Number of cancer genes per total identified genes per chromosome; chromosomes: 3, 8, 9, 10, 11, 13, 17 and 22. 4) Number of cancer genes per million base pairs per chromosome; chromosomes: 1, 3, 11, 17, 19 and 22. 5) Cancer genes which occur more than once in the same chromosome; chromosomes: 3, 10, 17 and 22.
In all five situations chromosomes: 3, 17 and 22 display prominent features. Chromosomes 10, 11 and 19 follow next in their deviating patterns. This indicates that these chromosomes ought to be the focus of particular attention in future cancer research, since still unknown gene constellations, or gene organization, may be responsible for this particular behaviour.
A quality test of the OMIM cancer gene selection. Mitelman et al. (2004) published a paper in which they surveyed all 44,750 cytogenetically abnormal neoplasms reported in the literature and listed 275 genes which are rearranged genes. These authors gave the designation of these genes, but not their location on the human chromosomes.
We have now localized these genes in the human complement. Of the 275, 269 could be localized accurately. The distribution is: 112 telons, 84 medons, 73 centrons. The X 2 is 9.02 and P = 0.011 which is significant. Moreover, the preponderance in the telomere region is followed by the same gradient distribution from the telomeres to the centromeres. The percentages from our data based on 994 cancer genes in figure 2 are: 42,5% telons, 31.3% medons, 26.3% centrons. The percentages from the data of Mitelman et al. are: 41.6% telons, 31.2% medons, and 27.1% centrons. The agreement could not be better. 
